{"entity":{"type":"insider","cik":"0001314596","url":"/insider/0001314596","json_url":"/insider/0001314596.json","name":"Katkin Keith","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":30,"first":"2006-05-25","last":"2026-05-04","span_basis":"filed_date"},"name_variants":[{"name":"Katkin Keith","source":"filing","n_filings":30,"first_seen":"2006-05-25","last_seen":"2026-05-04"}],"transactions":[{"id":6064922,"accession":"0001314596-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001314596-26-000002","line_url":"/filing/0001314596-26-000002#line-2","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15481.0,"shares_display":"15,481","price_per_share":8.28,"price_display":"8.28","price_state":"stated","total_value":128182.68,"total_display":"128,182.68","total_whole":"128,183","shares_owned_after":96294.0,"shares_owned_after_display":"96,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-04","scope":"insider"},{"id":4705238,"accession":"0001367644-25-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001367644-25-000136","line_url":"/filing/0001367644-25-000136#line-1","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Emergent BioSolutions Inc.","issuer_ticker":"EBS","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7844.0,"shares_display":"7,844","price_per_share":6.3,"price_display":"6.30","price_state":"stated","total_value":49417.2,"total_display":"49,417.20","total_whole":"49,417","shares_owned_after":86431.0,"shares_owned_after_display":"86,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-23","filed_date":"2025-05-28","scope":"insider"},{"id":4027620,"accession":"0000950170-25-074289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-074289","line_url":"/filing/0000950170-25-074289#line-1","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.112,"price_display":"9.11","price_state":"stated","total_value":91120.0,"total_display":"91,120.00","total_whole":"91,120","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-19","scope":"insider"},{"id":6393816,"accession":"0001562180-22-007125","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-007125","line_url":"/filing/0001562180-22-007125","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29899.0,"shares_display":"29,899","price_per_share":25.9009,"price_display":"25.90","price_state":"stated","total_value":774411.0091,"total_display":"774,411.01","total_whole":"774,411","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-07","scope":"insider","n_lines":2},{"id":6783028,"accession":"0001562180-22-007011","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001562180-22-007011","line_url":"/filing/0001562180-22-007011","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-04","scope":"insider","n_lines":2},{"id":6783024,"accession":"0001562180-22-007011","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-22-007011","line_url":"/filing/0001562180-22-007011","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180.0,"shares_display":"180","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider","n_lines":2},{"id":6783020,"accession":"0001562180-22-007011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-22-007011","line_url":"/filing/0001562180-22-007011","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Syndax Pharmaceuticals Inc","issuer_ticker":"SNDX","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3561.0,"shares_display":"3,561","price_per_share":25.0707,"price_display":"25.07","price_state":"stated","total_value":89276.7627,"total_display":"89,276.76","total_whole":"89,277","shares_owned_after":32000.0,"shares_owned_after_display":"32,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider","n_lines":2},{"id":7775914,"accession":"0000899243-19-028937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-028937","line_url":"/filing/0000899243-19-028937#line-2","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"Urovant Sciences Ltd.","issuer_ticker":"UROV","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (PEO;CEO/Urovant Sciences, Inc)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"PEO;CEO/Urovant Sciences, Inc.","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":12.78,"price_display":"12.78","price_state":"stated","total_value":1533600.0,"total_display":"1,533,600.00","total_whole":"1,533,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":7055826,"accession":"0001209191-14-076513","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-14-076513","line_url":"/filing/0001209191-14-076513#line-5","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62520.0,"shares_display":"62,520","price_per_share":16.93,"price_display":"16.93","price_state":"stated","total_value":1058463.6,"total_display":"1,058,463.60","total_whole":"1,058,464","shares_owned_after":914249.0,"shares_owned_after_display":"914,249","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2014-12-18","scope":"insider"},{"id":7055824,"accession":"0001209191-14-076513","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-076513","line_url":"/filing/0001209191-14-076513","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":215160.0,"shares_display":"215,160","price_per_share":16.95,"price_display":"16.95","price_state":"stated","total_value":3646962.0,"total_display":"3,646,962.00","total_whole":"3,646,962","shares_owned_after":976769.0,"shares_owned_after_display":"976,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-15","filed_date":"2014-12-18","scope":"insider","n_lines":2},{"id":6388359,"accession":"0001209191-14-064837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-064837","line_url":"/filing/0001209191-14-064837#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27567.0,"shares_display":"27,567","price_per_share":11.76,"price_display":"11.76","price_state":"stated","total_value":324187.92,"total_display":"324,187.92","total_whole":"324,188","shares_owned_after":732845.0,"shares_owned_after_display":"732,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-24","filed_date":"2014-10-24","scope":"insider"},{"id":6846450,"accession":"0001209191-14-050025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-050025","line_url":"/filing/0001209191-14-050025#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9670.0,"shares_display":"9,670","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":50864.2,"total_display":"50,864.20","total_whole":"50,864","shares_owned_after":760412.0,"shares_owned_after_display":"760,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-01","filed_date":"2014-08-01","scope":"insider"},{"id":7071673,"accession":"0001209191-14-038147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038147","line_url":"/filing/0001209191-14-038147#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":442212.0,"shares_display":"442,212","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":2215482.12,"total_display":"2,215,482.12","total_whole":"2,215,482","shares_owned_after":750082.0,"shares_owned_after_display":"750,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-28","filed_date":"2014-05-30","scope":"insider"},{"id":4758834,"accession":"0001209191-13-058257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-058257","line_url":"/filing/0001209191-13-058257#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29515.0,"shares_display":"29,515","price_per_share":2.6744,"price_display":"2.67","price_state":"stated","total_value":78934.916,"total_display":"78,934.92","total_whole":"78,935","shares_owned_after":445707.0,"shares_owned_after_display":"445,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-18","filed_date":"2013-12-20","scope":"insider"},{"id":5512391,"accession":"0001209191-13-050887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-050887","line_url":"/filing/0001209191-13-050887#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4385.0,"shares_display":"4,385","price_per_share":4.1363,"price_display":"4.14","price_state":"stated","total_value":18137.6755,"total_display":"18,137.68","total_whole":"18,138","shares_owned_after":475222.0,"shares_owned_after_display":"475,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-05","scope":"insider"},{"id":5133213,"accession":"0001209191-13-039085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-039085","line_url":"/filing/0001209191-13-039085#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15500.0,"shares_display":"15,500","price_per_share":4.8375,"price_display":"4.84","price_state":"stated","total_value":74981.25,"total_display":"74,981.25","total_whole":"74,981","shares_owned_after":479607.0,"shares_owned_after_display":"479,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-02","filed_date":"2013-08-02","scope":"insider"},{"id":4564817,"accession":"0001209191-13-027421","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-027421","line_url":"/filing/0001209191-13-027421","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250438.0,"shares_display":"250,438","price_per_share":3.259541926544694,"price_display":"3.26","price_state":"stated","total_value":816313.161,"total_display":"816,313.16","total_whole":"816,313","shares_owned_after":495107.0,"shares_owned_after_display":"495,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-17","scope":"insider","n_lines":2},{"id":2165096,"accession":"0001209191-12-055926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055926","line_url":"/filing/0001209191-12-055926#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18250.0,"shares_display":"18,250","price_per_share":2.5456,"price_display":"2.55","price_state":"stated","total_value":46457.2,"total_display":"46,457.20","total_whole":"46,457","shares_owned_after":119482.0,"shares_owned_after_display":"119,482","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-03","filed_date":"2012-12-05","scope":"insider"},{"id":3136572,"accession":"0001209191-12-035538","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-035538","line_url":"/filing/0001209191-12-035538#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":190125.0,"shares_display":"190,125","price_per_share":3.4966,"price_display":"3.50","price_state":"stated","total_value":664791.075,"total_display":"664,791.08","total_whole":"664,791","shares_owned_after":137732.0,"shares_owned_after_display":"137,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-25","filed_date":"2012-06-27","scope":"insider"},{"id":3446280,"accession":"0001209191-12-016315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-016315","line_url":"/filing/0001209191-12-016315#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.6093,"price_display":"2.61","price_state":"stated","total_value":26093.0,"total_display":"26,093.00","total_whole":"26,093","shares_owned_after":327857.0,"shares_owned_after_display":"327,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-06","filed_date":"2012-03-07","scope":"insider"},{"id":8907336,"accession":"0001209191-11-059754","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059754","line_url":"/filing/0001209191-11-059754#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17495.0,"shares_display":"17,495","price_per_share":2.3676,"price_display":"2.37","price_state":"stated","total_value":41421.162,"total_display":"41,421.16","total_whole":"41,421","shares_owned_after":190857.0,"shares_owned_after_display":"190,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-02","filed_date":"2011-12-06","scope":"insider"},{"id":9019328,"accession":"0001209191-11-057247","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-11-057247","line_url":"/filing/0001209191-11-057247#line-5","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109012.0,"shares_display":"109,012","price_per_share":2.5929,"price_display":"2.59","price_state":"stated","total_value":282657.2148,"total_display":"282,657.21","total_whole":"282,657","shares_owned_after":208352.0,"shares_owned_after_display":"208,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-17","filed_date":"2011-11-18","scope":"insider"},{"id":9019325,"accession":"0001209191-11-057247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-057247","line_url":"/filing/0001209191-11-057247#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":109013.0,"shares_display":"109,013","price_per_share":2.5896,"price_display":"2.59","price_state":"stated","total_value":282300.0648,"total_display":"282,300.06","total_whole":"282,300","shares_owned_after":208352.0,"shares_owned_after_display":"208,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-18","scope":"insider"},{"id":7758995,"accession":"0001209191-10-058457","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-10-058457","line_url":"/filing/0001209191-10-058457#line-3","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":195300.0,"shares_display":"195,300","price_per_share":4.0822,"price_display":"4.08","price_state":"stated","total_value":797253.66,"total_display":"797,253.66","total_whole":"797,254","shares_owned_after":208352.0,"shares_owned_after_display":"208,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-02","filed_date":"2010-12-03","scope":"insider"},{"id":7441951,"accession":"0001209191-10-052763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-052763","line_url":"/filing/0001209191-10-052763#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":5.7,"price_display":"5.70","price_state":"stated","total_value":114000.0,"total_display":"114,000.00","total_whole":"114,000","shares_owned_after":145852.0,"shares_owned_after_display":"145,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":7393186,"accession":"0001209191-10-044888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-044888","line_url":"/filing/0001209191-10-044888#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62874.0,"shares_display":"62,874","price_per_share":2.8289,"price_display":"2.83","price_state":"stated","total_value":177864.2586,"total_display":"177,864.26","total_whole":"177,864","shares_owned_after":167173.0,"shares_owned_after_display":"167,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-01","filed_date":"2010-09-02","scope":"insider"},{"id":7393184,"accession":"0001209191-10-044888","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-044888","line_url":"/filing/0001209191-10-044888#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":2.8628,"price_display":"2.86","price_state":"stated","total_value":114512.0,"total_display":"114,512.00","total_whole":"114,512","shares_owned_after":230047.0,"shares_owned_after_display":"230,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-31","filed_date":"2010-09-02","scope":"insider"},{"id":7515113,"accession":"0001209191-10-025235","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-10-025235","line_url":"/filing/0001209191-10-025235#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65906.0,"shares_display":"65,906","price_per_share":3.0555,"price_display":"3.06","price_state":"stated","total_value":201375.783,"total_display":"201,375.78","total_whole":"201,376","shares_owned_after":271367.0,"shares_owned_after_display":"271,367","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-03","filed_date":"2010-05-04","scope":"insider"},{"id":7515112,"accession":"0001209191-10-025235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-025235","line_url":"/filing/0001209191-10-025235#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":3.3093,"price_display":"3.31","price_state":"stated","total_value":132372.0,"total_display":"132,372.00","total_whole":"132,372","shares_owned_after":337273.0,"shares_owned_after_display":"337,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-30","filed_date":"2010-05-04","scope":"insider"},{"id":7457106,"accession":"0001209191-10-021805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-021805","line_url":"/filing/0001209191-10-021805#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.01,"price_display":"3.01","price_state":"stated","total_value":30100.0,"total_display":"30,100.00","total_whole":"30,100","shares_owned_after":377273.0,"shares_owned_after_display":"377,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-08","filed_date":"2010-04-09","scope":"insider"},{"id":7243173,"accession":"0001209191-10-019452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-019452","line_url":"/filing/0001209191-10-019452#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":78000.0,"total_display":"78,000.00","total_whole":"78,000","shares_owned_after":387273.0,"shares_owned_after_display":"387,273","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-29","filed_date":"2010-03-31","scope":"insider"},{"id":9266986,"accession":"0001209191-10-002754","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-10-002754","line_url":"/filing/0001209191-10-002754","is_derivative":false,"issuer_cik":"0001314596","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0001314596","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15025.0,"shares_display":"15,025","price_per_share":1.9484945091514143,"price_display":"1.95","price_state":"stated","total_value":29276.13,"total_display":"29,276.13","total_whole":"29,276","shares_owned_after":428590.0,"shares_owned_after_display":"428,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-11","scope":"insider","n_lines":7},{"id":7491787,"accession":"0001209191-10-001534","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-13","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":1.961,"price_display":"1.96","price_state":"stated","total_value":11766.0,"total_display":"11,766.00","total_whole":"11,766","shares_owned_after":418001.0,"shares_owned_after_display":"418,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":7491784,"accession":"0001209191-10-001534","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-12","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":1.9305,"price_display":"1.93","price_state":"stated","total_value":5984.55,"total_display":"5,984.55","total_whole":"5,985","shares_owned_after":429001.0,"shares_owned_after_display":"429,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":7491782,"accession":"0001209191-10-001534","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-11","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":1.9605,"price_display":"1.96","price_state":"stated","total_value":3921.0,"total_display":"3,921.00","total_whole":"3,921","shares_owned_after":424001.0,"shares_owned_after_display":"424,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":7491780,"accession":"0001209191-10-001534","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-10","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":1.9401,"price_display":"1.94","price_state":"stated","total_value":3880.2,"total_display":"3,880.20","total_whole":"3,880","shares_owned_after":426001.0,"shares_owned_after_display":"426,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":7491778,"accession":"0001209191-10-001534","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-9","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":925.0,"shares_display":"925","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":1785.25,"total_display":"1,785.25","total_whole":"1,785","shares_owned_after":432101.0,"shares_owned_after_display":"432,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"},{"id":7491776,"accession":"0001209191-10-001534","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-10-001534","line_url":"/filing/0001209191-10-001534#line-8","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":"0001314596","owner_name":"Katkin Keith","owner_display_name":"Katkin Keith","owner_url":"/insider/0001314596","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":1.94,"price_display":"1.94","price_state":"stated","total_value":1746.0,"total_display":"1,746.00","total_whole":"1,746","shares_owned_after":428001.0,"shares_owned_after_display":"428,001","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-01-05","filed_date":"2010-01-05","scope":"insider"}],"collapsed":true,"next_cursor":"2010-01-05|7491776","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":61,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001367644","name":"Emergent BioSolutions Inc.","url":"/issuer/0001367644","role":"Director","n_filings":2,"first_seen":"2025-05-28","last_seen":"2026-05-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001395937","name":"Syndax Pharmaceuticals Inc","url":"/issuer/0001395937","role":"Director","n_filings":3,"first_seen":"2022-10-04","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001740547","name":"Urovant Sciences Ltd.","url":"/issuer/0001740547","role":"Director, Officer (PEO;CEO/Urovant Sciences, Inc)","n_filings":1,"first_seen":"2019-12-11","last_seen":"2019-12-11"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Director, Officer (President and CEO)","n_filings":24,"first_seen":"2006-05-25","last_seen":"2014-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314596","retrieved_at":"2026-08-25T01:44:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}